$PFE Headlines The automaker the top performer
Post# of 72749
Posted On: 10/01/2014 1:02:27 PM
$PFE Headlines
The automaker the top performers like the most 46 min ago - Mark Hulbert
Do the top performers like any bond funds more than Bill Gross’ new fund? 11:30 a.m. Today - Mark Hulbert
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Pfizer held takeover talks with Actavis 1:32 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 3:21 p.m. Sept. 23, 2014 - Sue Chang
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Burger King, AbbVie among stocks hit by new tax inversion rules 2:40 p.m. Sept. 23, 2014 - Ben Eisen
Shire, AstraZeneca fall in London after U.S. tax move 12:19 p.m. Sept. 23, 2014 - Carla Mozee
The headwinds that Facebook faces 12:52 p.m. Sept. 11, 2014 - Mark Hulbert
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Portola Pharma anticoagulant antidote Phase 3 trial successful 52 min ago - Seeking Alpha
Zogenix submits sNDA for abuse deterrent Zohydro 10:37 a.m. Today - Seeking Alpha
Merrill Lynch’s Key Stock Picks for the Fourth Quarter 7:35 a.m. Today - 247WallSt.com
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Today - Seeking Alpha
Doctors Net Billions From Drug Firms 7:29 p.m. Sept. 30, 2014 - The Wall Street Journal Interactive Edition
GlycoMimetics Down Due to Delay in Rivipansel Study - Analyst Blog 3:10 p.m. Sept. 30, 2014 - Zacks.com
Pfizer (PFE) Aims at Women in New Viagra Ads 10:00 a.m. Sept. 30, 2014 - InvestorPlace.com
Retirees, You CAN Count On Dividend Stocks To Deliver From Here 9:54 a.m. Sept. 30, 2014 - Seeking Alpha
Top 10 Dow Dividend Stocks For October 9:39 a.m. Sept. 30, 2014 - InvestorPlace.com
Update: AstraZeneca Moves Closer To EU Approval For Moventig 3:41 a.m. Sept. 30, 2014 - Seeking Alpha
Tax Inversions Help Push Global M&A To 7-Year High 5:33 p.m. Sept. 29, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: PFE, CELG, BIIB 4:44 p.m. Sept. 29, 2014 - TheStreet.com
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down? 11:55 a.m. Sept. 29, 2014 - benzinga.com
Can Pfizer Grow Without A Big Acquisition? 10:55 a.m. Sept. 29, 2014 - Seeking Alpha
8 Deft Dow Dogs Denote 11% To 20% September Price Surge 7:38 a.m. Sept. 29, 2014 - Seeking Alpha
5 Great Value Funds to Buy Now 7:10 a.m. Sept. 29, 2014 - InvestorPlace.com
Retirement Strategy: The 'Buy The Dips Portfolio' Had A Blah Month, But There Are A Few New Opportunities Right Now 12:01 a.m. Sept. 29, 2014 - Seeking Alpha
'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions 2:50 a.m. Sept. 28, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - A Dreary September Update 12:01 a.m. Sept. 28, 2014 - Seeking Alpha
10 Healthcare Dogs: 12% To 35% September Upsides, 1 Runt Hits 75% 6:38 a.m. Sept. 27, 2014 - Seeking Alpha
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Today - GlobeNewswire
Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher 8:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 8:00 p.m. Sept. 29, 2014 - BusinessWire - BZX
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable 3:30 p.m. Sept. 26, 2014 - BusinessWire - BZX
GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel 9:01 a.m. Sept. 26, 2014 - GlobeNewswire
Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch 7:29 a.m. Sept. 26, 2014 - GlobeNewswire
Pfizer Completes Acquisition Of InnoPharma 8:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics 8:30 a.m. Sept. 24, 2014 - PR Newswire - PRF
Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts 10:39 a.m. Sept. 23, 2014 - BusinessWire - BZX
Kim Cattrall Encourages Women to Embrace Menopause with Style 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo 9:05 a.m. Sept. 22, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson's Disease 9:07 a.m. Sept. 16, 2014 - Marketwire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 9:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Sept. 4, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
The automaker the top performers like the most 46 min ago - Mark Hulbert
Do the top performers like any bond funds more than Bill Gross’ new fund? 11:30 a.m. Today - Mark Hulbert
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Pfizer held takeover talks with Actavis 1:32 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 3:21 p.m. Sept. 23, 2014 - Sue Chang
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Burger King, AbbVie among stocks hit by new tax inversion rules 2:40 p.m. Sept. 23, 2014 - Ben Eisen
Shire, AstraZeneca fall in London after U.S. tax move 12:19 p.m. Sept. 23, 2014 - Carla Mozee
The headwinds that Facebook faces 12:52 p.m. Sept. 11, 2014 - Mark Hulbert
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Portola Pharma anticoagulant antidote Phase 3 trial successful 52 min ago - Seeking Alpha
Zogenix submits sNDA for abuse deterrent Zohydro 10:37 a.m. Today - Seeking Alpha
Merrill Lynch’s Key Stock Picks for the Fourth Quarter 7:35 a.m. Today - 247WallSt.com
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Today - Seeking Alpha
Doctors Net Billions From Drug Firms 7:29 p.m. Sept. 30, 2014 - The Wall Street Journal Interactive Edition
GlycoMimetics Down Due to Delay in Rivipansel Study - Analyst Blog 3:10 p.m. Sept. 30, 2014 - Zacks.com
Pfizer (PFE) Aims at Women in New Viagra Ads 10:00 a.m. Sept. 30, 2014 - InvestorPlace.com
Retirees, You CAN Count On Dividend Stocks To Deliver From Here 9:54 a.m. Sept. 30, 2014 - Seeking Alpha
Top 10 Dow Dividend Stocks For October 9:39 a.m. Sept. 30, 2014 - InvestorPlace.com
Update: AstraZeneca Moves Closer To EU Approval For Moventig 3:41 a.m. Sept. 30, 2014 - Seeking Alpha
Tax Inversions Help Push Global M&A To 7-Year High 5:33 p.m. Sept. 29, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: PFE, CELG, BIIB 4:44 p.m. Sept. 29, 2014 - TheStreet.com
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down? 11:55 a.m. Sept. 29, 2014 - benzinga.com
Can Pfizer Grow Without A Big Acquisition? 10:55 a.m. Sept. 29, 2014 - Seeking Alpha
8 Deft Dow Dogs Denote 11% To 20% September Price Surge 7:38 a.m. Sept. 29, 2014 - Seeking Alpha
5 Great Value Funds to Buy Now 7:10 a.m. Sept. 29, 2014 - InvestorPlace.com
Retirement Strategy: The 'Buy The Dips Portfolio' Had A Blah Month, But There Are A Few New Opportunities Right Now 12:01 a.m. Sept. 29, 2014 - Seeking Alpha
'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions 2:50 a.m. Sept. 28, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - A Dreary September Update 12:01 a.m. Sept. 28, 2014 - Seeking Alpha
10 Healthcare Dogs: 12% To 35% September Upsides, 1 Runt Hits 75% 6:38 a.m. Sept. 27, 2014 - Seeking Alpha
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Today - GlobeNewswire
Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher 8:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 8:00 p.m. Sept. 29, 2014 - BusinessWire - BZX
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable 3:30 p.m. Sept. 26, 2014 - BusinessWire - BZX
GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel 9:01 a.m. Sept. 26, 2014 - GlobeNewswire
Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch 7:29 a.m. Sept. 26, 2014 - GlobeNewswire
Pfizer Completes Acquisition Of InnoPharma 8:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics 8:30 a.m. Sept. 24, 2014 - PR Newswire - PRF
Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts 10:39 a.m. Sept. 23, 2014 - BusinessWire - BZX
Kim Cattrall Encourages Women to Embrace Menopause with Style 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo 9:05 a.m. Sept. 22, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson's Disease 9:07 a.m. Sept. 16, 2014 - Marketwire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 9:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Sept. 4, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
(0)
(0)